4//SEC Filing
Vellanki Avanish 4
Accession 0001104659-23-090706
CIK 0001724979other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 9:17 PM ET
Size
8.0 KB
Accession
0001104659-23-090706
Insider Transaction Report
Form 4
Vellanki Avanish
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2023-08-09+133,250→ 133,250 totalExercise: $1.21Exp: 2033-08-09→ Common Stock (133,250 underlying) - Award
Stock Option (Right to Buy)
2023-08-09+266,500→ 266,500 totalExercise: $1.21Exp: 2033-08-09→ Common Stock (266,500 underlying)
Footnotes (2)
- [F1]This option represents a right to purchase a total of 266,500 shares of the Issuer's common stock, which will vest in equal installments on May 9, 2024 and February 9, 2025, subject to the Reporting Person's continued service to the Issuer.
- [F2]This option represents a right to purchase a total of 133,250 shares of the Issuer's common stock, which will vest in equal installments on May 9, 2024 and February 9, 2025, subject to the achievement of certain corporate goals and the Reporting Person's continued service to the Issuer.
Documents
Issuer
Rain Oncology Inc.
CIK 0001724979
Entity typeother
Related Parties
1- filerCIK 0001856682
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 9:17 PM ET
- Size
- 8.0 KB